Neumora Therapeutics Inc. Common Stock

NMRA | NASDAQ

$0.69

-$0.04 (-5.48%)

At close: Sep 21, 2026, 4:00 PM ET

$0.72

+$0.03 (+4.32%)

After-hours: Sep 21, 2026, 7:55 PM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	5M	n/a	668K	n/a	n/a	n/a
Gross Profit	-5M	n/a	-668K	n/a	n/a	n/a
Operating Income	-241.16M	-263.46M	-188.19M	-135.87M	-237.32M	-95.52M
Interest Income	8.34M	19.93M	16.61M	4.56M	n/a	n/a
Pretax Income	-236.8M	-243.61M	-235.66M	-130.9M	-237.31M	-99.27M
Net Income	-236.93M	-243.79M	-235.93M	-130.9M	-237.31M	-99.27M
Selling & General & Admin	60.09M	62.54M	44.81M	31.12M	24.55M	8.39M
Research & Development	176.07M	200.93M	142.72M	104.75M	212.78M	87.13M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	236.16M	263.46M	187.53M	135.87M	237.32M	95.52M
Interest Expense	3.22M	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	-668K	n/a	n/a	n/a
Cost & Expenses	241.16M	263.46M	188.19M	135.87M	237.32M	95.52M
Income Tax Expense	130K	178K	268K	n/a	n/a	n/a
Shares Outstanding (Basic)	163.39M	159.38M	158.83M	151.95M	151.95M	151.95M
Shares Outstanding (Diluted)	163.39M	159.38M	158.83M	151.95M	151.95M	151.95M
EPS (Basic)	-1.45	-1.53	-1.49	-0.86	-1.56	-0.65
EPS (Diluted)	-1.45	-1.53	-1.49	-0.86	-1.56	-0.65
EBITDA	-233.37M	-242.98M	-234.99M	-130.31M	-236.77M	-95.41M
EBIT	-233.58M	-243.61M	-235.66M	-130.9M	-237.31M	-95.52M
Depreciation & Amortization	208K	631K	668K	594K	538K	105K